Skip to main content
SpringerLink
Log in

Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor

  • Bone and Soft Tissue Sarcomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Puri A, Agrawal MG, Shah M, et al. Giant cell tumor of bone in children and adolescents. J Pediatr Orthop 2007;27:635–9

    PubMed  Google Scholar 

  2. Maki K, Harada T, Akiyami Y, et al. Giant cell tumor of the rib. Intern Med 2007;46:1151–2

    Article  PubMed  Google Scholar 

  3. Kapoor SK, Jain V, Agrawal M, et al. Primary malignant giant cell tumor of bone: a series of three rare cases. J Surg Orthop Adv 2007;16:89–92

    PubMed  Google Scholar 

  4. Gleason BC, Kleinman PK, Debelenko LV, et al. Novel karyotypes in giant cell-rich lesions of bone. Am J Surg Pathol 2007;31:926–32

    Article  PubMed  Google Scholar 

  5. Jones KB, DeYoung BR, Morcuende JA, et al. Ethanol as a local adjuvant for giant cell tumor of bone. Iowa Orthop J 2006;26:69–76

    Article  PubMed  Google Scholar 

  6. Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006;37:35–51

    Article  PubMed  Google Scholar 

  7. Werner M. Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 2006;30:484–9

    Article  PubMed  Google Scholar 

  8. Hu Y, Yu S. Gene expression of osteoprotegerin and osteoclast differentiation factor in giant cell tumor. Zhonghua Bing Li Xue Za Zhi 2002;31:128–31

    PubMed  Google Scholar 

  9. Atkins GJ, Kostakis P, Vincent C, et al. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 2006;21:1339–49

    Article  PubMed  CAS  Google Scholar 

  10. Hirai F, Nakayamada S, Okada Y, et al. Small GTPase Rho signaling is involved in beta1 integrin-mediated up-regulation of intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturation. Biochem Biophys Res Commun 2007;356:279–85

    Article  PubMed  CAS  Google Scholar 

  11. Desai B, Rogers MJ, Chellaiah MA. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 2007;6:18–21

    Article  PubMed  CAS  Google Scholar 

  12. Brazier H, Stephens S, Ory S, et al. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts. J Bone Miner Res 2006;21:1387–98

    Article  PubMed  CAS  Google Scholar 

  13. Holbourn KP, Sutton JM, Shore C, et al. Molecular recognition of an ADP-ribosyl transferase; clostridium botulinum C3 exoenzyme. Proc Natl Acad Sci 2005;102:5357–62

    Article  PubMed  CAS  Google Scholar 

  14. Harmey D, Stenbeck G, Nobes CD, et al. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res 2004;19:661–7

    Article  PubMed  CAS  Google Scholar 

  15. Singh R, Wang B, Shirraikar A, et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 1999;103:1561–70

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran

    Hamid Namazi

  2. Chamran Hospital-Shiraz-Iran, Shiraz, 0711, Islamic Republic of Iran

    Hamid Namazi

Authors
  1. Hamid Namazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hamid Namazi.

Additional information

Published by Springer Science+Business Media, Inc. © 2007 The Society of Surgical Oncology, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Namazi, H. Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor. Ann Surg Oncol 15, 2066–2067 (2008). https://doi.org/10.1245/s10434-007-9770-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9770-4

Keywords

Search

Navigation